Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
Patents for C07D 213 - Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members (63,273)
10/2003
10/15/2003CN1124259C Benzylsulfide derivative, process for its production and pesticide
10/14/2003US6632962 Caspase inhibitors and uses thereof
10/14/2003US6632946 Tetracyclic analogues of camptothecins, their preparation processes, their use as medicaments and the pharmaceutical compositions containing them
10/14/2003US6632945 Treating inflammation, autoimmune diseases, destructive bone disorders, proliferative disorders, infections, neurvous system disorders, reperfusion/ischemia in stroke, cardiovascular disorders, hypoxia, edema, fever, pain
10/14/2003US6632838 Use of bissulfonamides for producing medicines for the treatment of hyperlipidemia
10/14/2003US6632836 To treat autoimmune disorders, cardiac arrhythmias and the like
10/14/2003US6632834 Compositions and methods for treating conditions responsive to estrogen
10/14/2003US6632830 ACE-2 inhibiting compounds and methods of use thereof
10/14/2003US6632823 Substituted pyridine compounds useful as modulators of acetylcholine receptors
10/14/2003US6632816 Aromatic derivatives as HIV aspartyl protease inhibitors
10/14/2003US6632815 Show selectivity for factor Xa versus other proteases of coagulation or the fibrinolytic cascades
10/14/2003US6632809 Gyrase inhibitors and uses thereof
10/14/2003CA2122911C 1,3-substituted cycloalkenes and cycloalkanes as central nervous system agents
10/09/2003WO2003083063A2 Common ligand mimics: naphtoates
10/09/2003WO2003082853A1 New compounds
10/09/2003WO2003082824A1 Synthesis of 2,6-dicarbonylpyridines
10/09/2003WO2003082823A2 Pro-dyes containing compositions for dyeing keratinous fibers
10/09/2003WO2003082822A1 Phenethylacrylamide, methods for the production thereof and agents containing the same
10/09/2003WO2003082821A1 Process for producing 2,6-dihydroxy-3,4-dialkylpyridines
10/09/2003WO2003082808A1 Benzamide derivatives
10/09/2003WO2003082802A1 Acid and ester compounds and methods of using the same
10/09/2003WO2003082787A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082288A1 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
10/09/2003WO2003082280A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/09/2003WO2003082205A2 Compounds and methods
10/09/2003WO2003082191A2 Substituted 2,3-diphenyl pyridines
10/09/2003WO2003082190A2 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003WO2003052058A3 Dinuclear copper-based compound and ligand for nucleic acid scission and anticancer treatment
10/09/2003WO2002069947A3 Antisense oligonucleotides and trichostatin analogue histone deacetylase-4 inhibitors against cancer
10/09/2003WO2001079189A3 'amides of r-2-(aminoaryl)-propionic acids for use in theprevention of leucocyte activation'
10/09/2003US20030191340 Catalytic compositions and methods for asymmetric allylic alkylation
10/09/2003US20030191319 Alpha-and beta-amino acid hydroxyethylamino sulfonamides useful as retroviral protease inhibitors
10/09/2003US20030191317 Sulfonyl aryl or heteroaryl hydroxamic acid compounds
10/09/2003US20030191309 Administering N-substituted arylsulfonylamino hydroxamic acids to a patient for the treatment of arthritis and hepatic cirrhosis
10/09/2003US20030191306 Substituted N-Aliphatic-N-Aromatictertiary-Heteroalkylamines useful for inhibiting cholesteryl ester transfer protein activity
10/09/2003US20030191279 Of given formula; treatment of hyperproliferative disorders, pancreatitis, kidney disease, vasculogenesis or angiogenesis
10/09/2003US20030191262 Chain transfer agents for raft polymerization in aqueous media
10/09/2003US20030191177 Maintenance dosage of beta blocker; cardiovascular disorders
10/09/2003US20030191158 Nicotinamide derivatives and a tiotropium salt in combination for the treatment of diseases
10/09/2003US20030191156 Antidiabetic agents; dietetics
10/09/2003US20030191118 Inhibitors of alpha4 mediated cell adhesion
10/09/2003US20030191115 Lactam-containing compounds and derivatives thereof as factor Xa inhibitors
10/09/2003US20030191113 For agriculture
10/09/2003US20030190298 Use as skin lightening agents
10/09/2003CA2479744A1 Substituted 2,3-diphenyl pyridines
10/09/2003CA2479618A1 Spirocyclic amides as cannabinoid receptor modulators
10/09/2003CA2477764A1 Glucocorticoid mimetics, methods of making them, pharmaceutical compositions, and uses thereof
10/08/2003EP1349962A1 Methods and compositions for detecting polynucleotide duplex damage
10/08/2003EP1349856A2 Isoindolin-1-one glucokinase activators
10/08/2003EP1349847A1 Oxybenzamides derivatives as factor xa inhibitors
10/08/2003EP1349830A1 Tetralone derivatives as antitumor agents
10/08/2003EP0949248B1 6-(nonsubstituted or substituted) phenoxypicolinic acids, process of preparing the same, and agricultural/horticultural germicides containing the same
10/08/2003EP0946512B1 6-phenylpyridyl-2-amine derivatives useful as nos inhibitors
10/08/2003EP0923556B1 An asymmetric conjugate addition reaction
10/08/2003CN1447804A 1,3-bis-(substituted-phenyl)-2-propen-1-ones and their use to treat VCAM-1 mediated disorders
10/08/2003CN1447796A Novel heteroaryl derivatives and use thereof as anti-tumour agents
10/08/2003CN1447795A Biphenyl derivatives and use thereof as integrin inhibitors
10/08/2003CN1447789A Compounds to treat alzheimer's disease
10/08/2003CN1123566C Arylsulfonyl hydroxamic acid derivatives
10/08/2003CN1123564C Anti-inflammatory compounds
10/07/2003US6630589 Screening assays for compounds that are potentially useful for treating or preventing a proliferative disease. The assays are based on contacting a candidate compound with a cell containing a nucleic acid including a HER2 regulatory element
10/07/2003US6630512 Cell adhesion inhibitors
10/07/2003US6630503 Cell adhesion inhibitors
10/07/2003US6630495 Compound containing 2-pyridyl or its N-oxide
10/07/2003US6630493 Heterocyclically substituted amides, their preparation and use
10/07/2003US6630492 Lymphocyte function antigen-1 antagonists
10/07/2003US6630485 For therapy of inflammatory disease
10/07/2003US6630482 CFTR channel activator compounds and pharmaceutical compositions containing same
10/07/2003US6630463 Heterocycle-containing carboxylic acid derivative and drug containing the same
10/07/2003US6630004 Ready-to-use dyeing composition for keratinous fibers comprising, in dyeing medium, oxidizing agent chosen from hydrogen peroxide, urea hydrogen peroxide, alkali metal bromates, persalts and enzymes, and specified oxidation base
10/07/2003CA2302436C Branched alkoxy-substituted 2-aminopyridines
10/07/2003CA2279692C Novel 4-amino-1-arylpyridin-2-ones having anticonvulsive activity and processes for their preparation
10/07/2003CA2270026C Substituted bicyclic derivatives for treating central nervous system disorders
10/07/2003CA2263957C Diarylmethyl piperazine derivatives as delta opioid agonists
10/07/2003CA2225198C Method for the synthesis of deoxypyridinoline
10/07/2003CA2094808C Oxysulfonyl urea acat inhibitors
10/02/2003WO2003080737A1 Azo dyes
10/02/2003WO2003080576A2 Pyridinyl amides and compositions thereof for use as fungicides
10/02/2003WO2003080575A1 Process for producing heterocyclic aldehyde
10/02/2003WO2003080564A1 Menthol substituted antithrombotic pai-1 inhibitors
10/02/2003WO2003080559A1 Oligofluorenylene compounds
10/02/2003WO2003080556A1 Amine derivative with potassium channel regulatory function, its preparation and use
10/02/2003WO2003080553A1 Cyclopentene derivatives
10/02/2003WO2003080060A1 Substituted piperazine antithrombotic pai-1 inhibitors
10/02/2003WO2003080053A1 Combination treatments for chemokine-mediated diseases
10/02/2003WO2003079984A2 Substituted tetracycline compounds
10/02/2003WO2003045912A8 Inhibitors of factor xa and other serine proteases involved in the coagulation cascade
10/02/2003WO2003044015A3 Substituted heteroarylalkanoic acids and their use as aldose reductase inhibitors
10/02/2003US20030187289 A biphenyl-alkyloxy-benzoylamino-propionic acid or amide derivatives; treating thrombosis, cardiovascular disorders, arteriosclerosis, inflammation, tumor, osteoporosis, angioplasty aftertreatment
10/02/2003US20030187276 Hydrophobic polyamine analogs and methods for their use
10/02/2003US20030187271 Synthesis of 2, 6-dicarbonylpyridines
10/02/2003US20030187042 Modulate gene expression; antitumor agents; cardiovascular disorders; anticholesterol agents; antilipemic agents
10/02/2003US20030187037 Cardiovascular disorders; antiinflammatory agents; antitumor agents
10/02/2003US20030187033 Potassium channel modulators; cardiovascular disorders; antiarrhythmia agents
10/02/2003US20030187032 Pharmaceutical compositions comprising 1-isopropyl-3-[(4-m-toluidino-3-pyridyl)sulphonyl]-urea as active ingredient
10/02/2003US20030187031 Antiinflammatory agents; autoimmune disease; rheumatic disorders
10/02/2003US20030187026 Antiproliferative agents
10/02/2003US20030187023 Sulfone derivatives, process for their production and use thereof
10/02/2003US20030187021 Treatment of CNS disorders using CNS target modulators
10/02/2003US20030187015 Viricides; anticancer agents
1 ... 316 317 318 319 320 321 322 323 324 325 326 327 328 329 330 331 332 333 334 335 336 ... 633